Here is the latest shareholding Pattern of PHARMAIDS PH. For more details, see the PHARMAIDS PH financial fact sheet and PHARMAIDS PH share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Jun-22 |
3
Sep-22 |
3
Dec-22 |
3
Mar-23 |
3
Jun-23 |
3
Sep-23 |
3
Dec-23 |
3
Mar-24 |
||
---|---|---|---|---|---|---|---|---|---|---|
Indian Promoters | % | 20.70 | 20.97 | 16.52 | 9.95 | 9.94 | 9.70 | 9.25 | 5.64 | |
Foreign Promoters | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Promoters | % | 20.70 | 20.97 | 16.52 | 9.95 | 9.94 | 9.70 | 9.25 | 5.64 | |
Mutual Funds | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Financial institution/Banks/Insurance | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Government | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
FII | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Institution | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Bodies Corporate | % | 0.00 | 0.32 | 0.26 | 0.91 | 0.90 | 0.22 | 0.17 | 4.54 | |
Individuals | % | 78.73 | 74.19 | 70.98 | 81.71 | 81.28 | 81.93 | 60.78 | 41.06 | |
NRIs/OCBs | % | 0.00 | 0.13 | 0.56 | 0.32 | 0.78 | 1.05 | 1.05 | 0.65 | |
ADR/GDR | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Others | % | 0.57 | 4.39 | 11.68 | 7.11 | 7.10 | 7.10 | 28.75 | 48.11 | |
Total Non-Institution | % | 79.30 | 79.03 | 83.48 | 90.05 | 90.06 | 90.30 | 90.75 | 94.36 | |
Total Public | % | 79.00 | 79.00 | 83.00 | 90.00 | 90.00 | 90.00 | 91.00 | 94.00 | |
Grand Total | % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
Pledged Promoter Holding | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Subscriber Feature |
More Pharmaceuticals Company Shareholding Pattern: ZYDUS LIFESCIENCES CIPLA DIVIS LABORATORIES SUN PHARMA DR. REDDYS LAB
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.